Surzen Biotherapeutics

Seed
surzenbio.com Biotech & Healthcare Okinawa, Japan
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Aug 18, 2026
Investors Undisclosed
Decision Makers 3 Verified

About Surzen Biotherapeutics

Surzen Biotherapeutics is developing peptide therapeutics that enhance the effectiveness of opioid analgesics.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Okinawa, Japan
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website surzenbio.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Seed announced

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Surzen Biotherapeutics.

Funding History

1 Round
Seed · Aug 18, 2026
Undisclosed

Founders & Leadership

1

Peng Zhou

Founder

Work email & phone locked Unlock →

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts